Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|May 28, 2010
Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletionAndrew N Phillips, Fiona C Lampe, Colette J Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 2, 2007
Response to efavirenz-containing regimens in previously antiretroviral-naive HIV-positive patients: the role of genderColette J Smith, Caroline A Sabin, Mike S Youle, et al.
AIDS (London, England)|November 10, 2020
All-cause hospitalization according to demographic group in people living with HIV in the current antiretroviral therapy eraSophia M Rein, Fiona C Lampe, Margaret A Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapyAnna Maria Geretti, Zoe V Fox, Clare L Booth, et al.
European Heart Journal|May 10, 2006
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertensionMark H Williams, Clive E Handler, Raza Akram, et al.
The Journal of Infectious Diseases|October 23, 2004
Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapyColette J Smith, Caroline A Sabin, Mike S Youle, et al.
AIDS (London, England)|June 4, 2008
Stability of antiretroviral regimens in patients with viral suppressionRebecca K Lodwick, Colette J Smith, Mike Youle, et al.
AIDS (London, England)|September 28, 2012
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patientsRicha Singh, Neal Marshall, Colette J Smith, et al.
AIDS (London, England)|March 20, 2010
Long-term trends in adherence to antiretroviral therapy from start of HAARTValentina Cambiano, Fiona C Lampe, Alison J Rodger, et al.
Pageof 6